9.82
Fortrea Holdings Inc stock is traded at $9.82, with a volume of 855.27K.
It is up +1.50% in the last 24 hours and down -2.77% over the past month.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
See More
Previous Close:
$9.675
Open:
$10.32
24h Volume:
855.27K
Relative Volume:
0.50
Market Cap:
$891.66M
Revenue:
$2.98B
Net Income/Loss:
$-300.00M
P/E Ratio:
-2.8882
EPS:
-3.4
Net Cash Flow:
$225.00M
1W Performance:
+2.40%
1M Performance:
-2.77%
6M Performance:
+89.58%
1Y Performance:
-48.12%
Fortrea Holdings Inc Stock (FTRE) Company Profile
Name
Fortrea Holdings Inc
Sector
Industry
Phone
877-495-0816
Address
8 MOORE DRIVE, DURHAM
Compare FTRE with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
FTRE
Fortrea Holdings Inc
|
9.82 | 878.49M | 2.98B | -300.00M | 225.00M | -3.40 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-04-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
May-02-25 | Initiated | Truist | Hold |
Apr-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
Dec-06-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
Aug-08-24 | Downgrade | Evercore ISI | Outperform → In-line |
Jul-24-24 | Resumed | Barclays | Equal Weight |
Jun-06-24 | Initiated | Goldman | Neutral |
May-29-24 | Initiated | TD Cowen | Hold |
May-28-24 | Initiated | Mizuho | Neutral |
Mar-22-24 | Initiated | Robert W. Baird | Neutral |
Mar-06-24 | Initiated | Deutsche Bank | Hold |
Jan-05-24 | Initiated | William Blair | Mkt Perform |
Jan-04-24 | Initiated | Jefferies | Buy |
Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
Dec-01-23 | Upgrade | Evercore ISI | In-line → Outperform |
Nov-14-23 | Upgrade | Barclays | Equal Weight → Overweight |
Oct-19-23 | Initiated | Citigroup | Neutral |
Sep-14-23 | Initiated | Evercore ISI | In-line |
Aug-16-23 | Initiated | Barclays | Equal Weight |
Aug-07-23 | Initiated | BofA Securities | Underperform |
View All
Fortrea Holdings Inc Stock (FTRE) Latest News
Momentum divergence signals in Fortrea Holdings Inc. chartJuly 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
Using economic indicators to assess Fortrea Holdings Inc. potentialJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Can trapped investors hope for a rebound in Fortrea Holdings Inc.July 2025 Market Mood & Verified Technical Trade Signals - newser.com
Top chart patterns to watch in Fortrea Holdings Inc.July 2025 Summary & Stock Timing and Entry Methods - newser.com
Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc.FTRE - FinancialContent
Fortrea jumps as Baird upgrades on long-term opportunity - MSN
Barclays Lifts Fortrea (FTRE) PT to $8 Amid Q3 2025 Life Sciences Preview - Yahoo Finance
Fortrea (NASDAQ:FTRE) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - Yahoo Finance
Fortrea (NASDAQ:FTRE) Raised to Strong-Buy at Zacks Research - MarketBeat
Why retail traders accumulate Fortrea Holdings Inc. (K67) stockJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Automated trading signals detected on Fortrea Holdings Inc.Rate Hike & High Yield Equity Trading Tips - newser.com
What machine learning models say about Fortrea Holdings Inc.Volume Spike & Fast Moving Stock Watchlists - newser.com
How analysts rate Fortrea Holdings Inc. stock todayCEO Change & Daily Market Momentum Tracking - newser.com
Is Fortrea Holdings Inc. (K67) stock vulnerable to rate hikes2025 Earnings Surprises & Safe Entry Point Alerts - newser.com
Fortrea Holdings Hits Day High with 8.81% Surge in Stock Price - Markets Mojo
Fortrea Holdings, Inc. (FRTE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Fortrea Holdings Inc. (K67) stock worth holding before Fed meetingJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Fortrea (NASDAQ:FTRE) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Why Fortrea (FTRE) Stock Is Up Today - TradingView
Fortrea (NASDAQ:FTRE) Shares Gap Up on Analyst Upgrade - MarketBeat
FTRE's Price Target Raised by Evercore ISI Group to $11.00 | FTR - GuruFocus
Evercore ISI Forecasts Strong Price Appreciation for Fortrea (NASDAQ:FTRE) Stock - MarketBeat
111 Capital Buys 28,200 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
Wealth Enhancement Advisory Services LLC Buys 62,554 Shares of Fortrea Holdings Inc. $FTRE - MarketBeat
What analysts say about Fortrea Holdings Inc stockSupport Level Holds & Start Building Capital with Zero Risk - earlytimes.in
Fortrea Holdings (NASDAQ:FTRE) Has Debt But No Earnings; Should You Worry? - 富途牛牛
Real time scanner hits for Fortrea Holdings Inc. explainedJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Why Fortrea Holdings Inc. is moving todayMarket Trend Report & High Return Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FRTE) And Encourages Shareholders to Connect - ACCESS Newswire
2025-10-05 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FRTE) And Encourages Shareholders to Connect | Press Release - Stockhouse
Using data models to predict Fortrea Holdings Inc. stock movementJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Identifying reversal signals in Fortrea Holdings Inc.Sell Signal & Fast Exit and Entry Strategy Plans - newser.com
Will Fortrea Holdings Inc. stock benefit from AI adoptionJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-10-05 05:33:38 - newser.com
What the charts say about Fortrea Holdings Inc. todayBond Market & Entry Point Confirmation Signals - newser.com
Will Fortrea Holdings Inc. stock outperform Nasdaq indexJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
How Recent Developments Are Shaping the Story and Valuation of Fortrea Holdings - Yahoo Finance
Published on: 2025-10-03 07:20:31 - newser.com
Where Fortrea Holdings Stands With Analysts - Benzinga
Fortrea price target raised to $8 from $6 at Barclays - TipRanks
The Best Biotech Stocks to Buy - Morningstar
Fortrea (NASDAQ:FTRE) Trading Up 7.2%What's Next? - MarketBeat
Fortrea Holdings Inc Stock (FTRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fortrea Holdings Inc Stock (FTRE) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Parks Robert | Chief Accounting Officer |
Sep 16 '25 |
Sale |
9.95 |
7,338 |
73,013 |
19,046 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):